Brief: Bioton replaces its insulin distributor in China

Bioton SA

24/09/2015 08:24

Sept 24 (Reuters) - Bioton SA  BIOP.WA : 
    * Said on Wednesday that as of Dec. 31 Bioton, SciGen 
Limited and Bayer Healthcare Company Limited dissolve all 
agreements signed between them by Sept. 23  
    * Dissolution concerns, among others, contract from July 9, 
2009 for the delivery and distribution of insulin in China and 
contract from March 27, 2013 for delivery and distribution of 
insulin pens in China 
    * Together with SciGen, signs deal with Harbin Gloria 
Pharmaceuticals Co. Ltd. for delivery and distribution of 
insulin in China  
    * Harbin Gloria Pharmaceuticals to become Chinese 
distributor as of Jan. 1, 2016, after dissolution of contract 
with Bayer Healthcare Company enters into force 
    * Singapore-based SciGen is a unit of Bioton       
 
     
 Source text for Eikon:  ID:nEM2302991   ID:nEM2302993  
     
 Further company coverage:  BIOP.WA   
    
 
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 58 698 3920;))